InvestorsHub Logo
Followers 71
Posts 9289
Boards Moderated 0
Alias Born 04/28/2017

Re: None

Friday, 08/02/2019 7:26:41 PM

Friday, August 02, 2019 7:26:41 PM

Post# of 136
Developing Treatments for Traumatic Brain Injuries (TBIs)
https://www.angelmd.co/en/startups/qrons-inc

Product Overview
We have two products candidates for treating TBIs, both integrating proprietary, modified mesenchymal stem cells (“MSCs”) and smart synthetic material. QS100TM is an injury specific, 3D printable, implantable MSCs-synthetic hydrogel, to treat penetrating brain injuries and QS200TM is an injectable MSCs-synthetic

PRODUCT SNAPSHOT
Product Status: Prototype Complete
Clinical Trials: Pre-Clinical
Patents: Provisional
Market Size: $5B

COMPETITIVE ADVANTAGE
We believe we are the only Company working on a treatment for TBI. Other companies are working on detection systems, but not treating the TBI.

$QRON